COMP <GO>
OVID vs MPLT // REVENUE GROWTH (YOY)
Ovid Therapeutics Inc. (NASDAQ) VS. MapLight Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: OVID 3
— MPLT 1
■ METRIC PARITY
LAST: $2.56 (+4.49%) • MKT CAP: $500.0M
revenue-growth
180.00%
LAST: $7.72 (-3.26%) • MKT CAP: $500.1M
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OVID VS. MPLT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OVID | MPLT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.50% | -32.40% | +3.90 | OVID | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.67% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.46 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | OVID | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.9 | 33.9 | +23.00 | OVID | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $500.0M | $500.1M | -$89.7K | MPLT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OVID REV | MPLT REV | OVID GROSS % | MPLT GROSS % | OVID FCF | MPLT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.3M | $0 | — | — | -$38.3M | -$138.6M |
| FY 2024 | $566.0K | $0 | — | — | -$56.0M | -$79.6M |
| FY 2023 | $392.0K | — | — | — | -$45.8M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OVID // BETA —
MPLT // BETA —